Atlas Trials

A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis

Clinical trial NCT02475772 · COMPLETED

Trial details

NCT number
NCT02475772
Sponsor
Clemens Tempfer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2016-11-01
Primary completion
2018-05-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.